Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 350 participants.
Also called NCT01371058
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 350 participants
- Sponsor
- Registry
-
NCT01371058
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01371058. Randomized; no masking; primary purpose prevention. Start 2011-03 (registry gives no type); primary completion 2012-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)
- Acronym
- spirit
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- high maintenance clopidogrel
- Intervention (Drug)
- routine dual antiplatelet
- Intervention (Drug)
- policosanol plus dual antiplatelet
- Lead sponsor
- Shenyang Northern Hospital
Record details
- Record id
cardio:ct-nct01371058- Content hash
01d2ae8dff826abfcbd5983a1842fbd9a1a0e66e875aa0fb368f62d376bbb681